Under the Microscope: A Look Into the Role of Critical Care Pharmacists During the COVID-19 Pandemic.
Payal K GurnaniGary D PeksaNicholas G PanosJoshua M DeMottPublished in: Journal of pharmacy practice (2021)
Among disciplines, the COVID-19 pandemic has reinforced the importance of critical care pharmacists in assuming responsibility for managing medication therapy in direct patient care settings. Historically, pharmacists have been relied upon for prospective evaluation of drug therapy for appropriate indications, dosage, drug interactions, and drug allergies; monitoring patients' pharmacotherapeutic regimens for effectiveness and adverse effects; providing drug information to providers; and educating health professionals regarding drug therapies. Specific to COVID-19, pharmacists have been an integral member of the multidisciplinary rounding team, assisting with drug shortages and strategies for drug conservation; participating in emergencies, such as advanced cardiac life support (ACLS) and rapid sequence intubations; and creating as well as integrating evidence-based guidelines and pathways during the pandemic into clinical practice. The purpose of this article is to demonstrate the various roles of critical care pharmacists among the healthcare team in caring for critically ill COVID-19 patients.
Keyphrases
- healthcare
- sars cov
- clinical practice
- coronavirus disease
- adverse drug
- end stage renal disease
- systematic review
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- quality improvement
- newly diagnosed
- stem cells
- heart failure
- primary care
- mesenchymal stem cells
- peritoneal dialysis
- prognostic factors
- quantum dots